Detalles de la búsqueda
1.
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.
J Immunol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758119
2.
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.
Int J Urol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424729
3.
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Cancer Immunol Immunother
; 72(6): 1903-1915, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729213
4.
Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study.
Int J Urol
; 30(6): 547-553, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941084
5.
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.
Int J Urol
; 30(9): 788-796, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528632
6.
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.
Int J Clin Oncol
; 27(1): 194-201, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599725
7.
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
Int J Clin Oncol
; 27(5): 958-968, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142962
8.
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Int J Urol
; 29(12): 1477-1487, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36070138
9.
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
World J Urol
; 39(7): 2491-2497, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079252
10.
Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma.
BMC Urol
; 21(1): 124, 2021 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34496819
11.
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.
Int J Urol
; 28(9): 955-963, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148264
12.
Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
Int J Urol
; 28(2): 208-214, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33283389
13.
[The Effect of Using Regional Cooperation Critical Pathway for Cancer Patients].
Gan To Kagaku Ryoho
; 48(6): 753-758, 2021 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-34139718
14.
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Cancer
; 126(17): 3961-3971, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573779
15.
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.
Jpn J Clin Oncol
; 50(7): 810-820, 2020 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32188988
16.
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Int J Clin Oncol
; 25(12): 2107-2114, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770439
17.
Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy.
Jpn J Clin Oncol
; 49(11): 1037-1042, 2019 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31436793
18.
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer.
Int J Clin Oncol
; 24(12): 1596-1604, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446511
19.
Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy.
Health Qual Life Outcomes
; 16(1): 7, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304808
20.
Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.
Int J Urol
; 25(5): 492-499, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633398